Carette et al. reported to generate the iPS cells derived from human chronic myeloid leukemia cells by using the reprogramming factors (Oct4, Sox2, Klf4 and c-Myc) [47]. The gene discussed is MYC; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.